Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Lobular Carcinoma of the Breast: Why Does the Incidence Continue to Rise?

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Thomas M, Kelly ED, Abraham J, Kruse M. Invasive lobular breast cancer: a review of pathogenesis, diagnosis, management, and future directions of early stage disease. Semin Oncol. 2019;46(2):121–132. https://doi.org/10.1053/j.seminoncol.2019.03.002.

    Article  PubMed  Google Scholar 

  2. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet. 1997;350:1047–1059. https://doi.org/10.1186/bcr486.

    Article  Google Scholar 

  3. Chen C, Weiss NS, Newcomb P, Barlow W, White E. Hormone replacement therapy in relation to breast cancer. JAMA. 2002;287(6):734–741.

    Article  CAS  Google Scholar 

  4. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA. 2002;288(3):321–333.

    Article  CAS  Google Scholar 

  5. Findlay-Shirras LJ, Lima I, Smith G, Clemons M, Arnaout A. Population trends in lobular carcinoma of the breast: the Ontario experience. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08895-8.

    Article  PubMed  Google Scholar 

  6. Bland K, Copeland E, Klimberg VS, Gradishar WJ. The breast: comprehensive management of benign and malignant diseases. 5th ed. Philadelphia, PA: Elsevier; 2017.

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of Ottawa, Ottawa, Canada

    Lisa Findlay-Shirras MBBS, MSc & Angel Arnaout MD, MSc, FRCSC, FACS, MBA

  2. The Ottawa Hospital Research Institute, Ottawa, Canada

    Angel Arnaout MD, MSc, FRCSC, FACS, MBA

  3. Department of General Surgery, The Ottawa Hospital, Ottawa, Canada

    Lisa Findlay-Shirras MBBS, MSc & Angel Arnaout MD, MSc, FRCSC, FACS, MBA

Authors
  1. Lisa Findlay-Shirras MBBS, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Angel Arnaout MD, MSc, FRCSC, FACS, MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lisa Findlay-Shirras MBBS, MSc.

Ethics declarations

Disclosures

Lisa Findlay-Shirras and Angel Arnaout have no commercial interests or financial or material support to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Findlay-Shirras, L., Arnaout, A. ASO Author Reflections: Lobular Carcinoma of the Breast: Why Does the Incidence Continue to Rise?. Ann Surg Oncol 27 (Suppl 3), 695–696 (2020). https://doi.org/10.1245/s10434-020-08984-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-08984-8

Search

Navigation